Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.

The move raises privacy concerns as the drugmaker takes control of the genetic data of millions of clients of the once-sizzling DNA-testing startup.

Nvidia stock pared losses Monday as market turmoil overshadowed AI chip news during the Computex Taipei tech expo.